Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply
JAMA
.
2015 Sep 15;314(11):1177-8.
doi: 10.1001/jama.2015.9719.
Authors
Willemijn J Jansen
1
,
Rik Ossenkoppele
2
,
Pieter Jelle Visser
1
Affiliations
1
Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
2
Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands.
PMID:
26372591
DOI:
10.1001/jama.2015.9719
No abstract available
Publication types
Letter
Comment
MeSH terms
Amyloid beta-Peptides / analysis*
Apolipoprotein E4 / genetics*
Brain / pathology*
Cognitive Dysfunction / pathology*
Female
Humans
Male
Substances
Amyloid beta-Peptides
Apolipoprotein E4